Rebecca E Daly Selected Research

Kdo2-lipid A

1/2021

Gut microbiome in Schizophrenia: Altered functional pathways related to immune modulation and atherosclerotic risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca E Daly Research Topics

Disease

3	Schizophrenia (Dementia Praecox) 01/2021 - 10/2015
2	Coronary Disease (Coronary Heart Disease) 01/2021 - 01/2019
2	Mental Disorders (Mental Disorder) 01/2019 - 10/2015
1	Inflammation (Inflammations) 01/2019
1	Insulin Resistance 01/2019
1	Obesity 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2015
1	Cognitive Dysfunction 10/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2015
1	Psychotic Disorders (Schizoaffective Disorder) 10/2015

Drug/Important Bio-Agent (IBA)

3	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 10/2015
1	CytokinesIBA 01/2021
1	Kdo2-lipid AIBA 01/2021
1	tertiary amine N-oxide reductase (trimethylamine N-oxide reductase)IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Biological ProductsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 10/2015
1	C-Reactive ProteinIBA 10/2015